Screener
Aurinia Pharmaceuticals AUPH EV / EBITDA
EV / EBITDA at other companies
Other financials
Where this comes from
Calculated from Aurinia Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The source filing: Aurinia Pharmaceuticals’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 8:16 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001600620-26-000062
FAQ
- What is Aurinia Pharmaceuticals's EV / EBITDA?
- Aurinia Pharmaceuticals (AUPH) reported EV / EBITDA of 12.2× in Q2 2026.
- How has Aurinia Pharmaceuticals's EV / EBITDA changed year-over-year?
- Aurinia Pharmaceuticals's EV / EBITDA decreased by 22.7% year-over-year, from 15.8× to 12.2×.
- What does EV / EBITDA mean?
- Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.
Ask your AI about Aurinia Pharmaceuticals's ev / ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude